Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nathaniel Mabe, Ph.D., Pharm.D.

Concepts (118)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Nathaniel Mabe's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Nathaniel Mabe has written about over time.
RGS Proteins, 2 publications between 2011 and 2016, average publication date January 2014. Apoptosis Regulatory Proteins, 2 publications between 2018 and 2018, average publication date May 2018. Drug Resistance, Neoplasm, 1 publications between 2018 and 2018, average publication date August 2018. Tumor Suppressor Proteins, 1 publications between 2018 and 2018, average publication date August 2018. Epithelial-Mesenchymal Transition, 2 publications between 2018 and 2020, average publication date September 2019. Gene Silencing, 2 publications between 2018 and 2020, average publication date September 2019. Mice, Nude, 3 publications between 2018 and 2020, average publication date February 2020. Neoplasm Recurrence, Local, 6 publications between 2018 and 2022, average publication date February 2020. Inflammation, 2 publications between 2019 and 2020, average publication date March 2020. Mammary Neoplasms, Animal, 2 publications between 2020 and 2020, average publication date June 2020. Receptor-Interacting Protein Serine-Threonine Kinases, 2 publications between 2020 and 2020, average publication date June 2020. Histone-Lysine N-Methyltransferase, 1 publications between 2020 and 2020, average publication date November 2020. Gene Expression Regulation, Neoplastic, 8 publications between 2018 and 2024, average publication date April 2021. Epigenesis, Genetic, 3 publications between 2020 and 2024, average publication date October 2021. Gangliosides, 1 publications between 2022 and 2022, average publication date July 2022. Vaccinia, 1 publications between 2022 and 2022, average publication date October 2022. Neuroblastoma, 3 publications between 2022 and 2024, average publication date March 2023.

To see the data from this visualization as text, click here.
Mabe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (118)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.